Highlights
New technologies for imaging the human body (2012)
New Zealand technologies being developed to perform delicate new procedures, locate sites where cancer drugs are active, and model a person’s entire skin, were just some of the top
read the full story
PhD student part of international drug development programme (2012)
Maurice Wilkins Centre-funded PhD student Matthew Bull is part of international research on a new class of immunosuppressants being developed initially to protect bone marrow trans
read the full story
The future of vaccines (2012)
Maurice Wilkins Centre investigator Professor Sarah Hook from the University of Otago is developing new vaccine formulations – including needle-free vaccines and vaccines for cance
read the full story
New Zealand TB drug candidate selected (2012)
In late 2012 a promising New Zealand compound targeting treatment-resistant tuberculosis (TB) was selected as a drug candidate by international non-profit drug developer the Global
read the full story
Rheumatic fever - Research strengths confront national need (2012)
The Maurice Wilkins Centre prioritises rheumatic fever research, and its work built momentum in 2012 with the appointment of a specialist researcher, funding of two research projec
read the full story
Creating connections with China (2012)
An official visit by State Councillor Liu Yandong, now a Vice-Premier of the People’s Republic of China, was the culmination of the Maurice Wilkins Centre’s work during 2012 to bui
read the full story
A core of celebrated scientists (2012)
Maurice Wilkins Centre investigators continued to win acclaim in 2012, ending the year with seven medals at the Royal Society of New Zealand research honours event, including the t
read the full story
Scientists and teachers in unique partnership (2012)
Science teachers from Auckland and Northland leapt at the opportunity for an intensive update on the latest in biomedical science, at a unique Maurice Wilkins Centre event in 2012.
read the full story
New Zealand patients trial local cancer drug (2012)
Cancer patients in Auckland, Waikato and the United States are participating in the first clinical trial of an exciting new drug invented in New Zealand.
read the full story